TRPX
Therapix Biosciences Ltd.
TRPX
TRPX
Delisted
TRPX was delisted on the 1st of July, 2020.
6 hedge funds and large institutions have $93K invested in Therapix Biosciences Ltd. in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$17K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$52K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $52K | -$5.7K | -1,000 | -10% |
|
2
Acadian Asset Management
Boston,
Massachusetts
| $23K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $17K | +$17K | +2,900 | New |
|
|
PA
4
Parallel Advisors
San Francisco,
California
| $1K | – | – | – |
|